Analyst Ratings for Inhibikase Therapeutics Inc (IKT)
IKT Rating Summary
IKT Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.83 (+176.5%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Rating Score: 8.6 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | Oppenheimer | Mazahir Alimohamed | New Coverage | Outperform (N/A) |
5.00 (N/A) |
1.67 (2.11) |
26.35% | Details |
| 3/4/2026 | Ladenburg Thalmann | Aydin Huseynov | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.91 (2.11) |
10.47% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


